{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:22:31Z","timestamp":1780359751689,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11427-019-9550-4","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T15:10:25Z","timestamp":1562685025000},"page":"737-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses"],"prefix":"10.1007","volume":"63","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"9550_CR1","first-page":"953","volume":"26","author":"AA Abdin","year":"2013","unstructured":"Abdin, A.A., Ashour, D.S., and Shoheib, Z.S. (2013). Artesunate effect on schistosome thioredoxin glutathione reductase and cytochrome c peroxidase as new molecular targets in Schistosoma mansoni-infected mice. Biomed Environ Sci, 26, 953\u2013961.","journal-title":"Biomed Environ Sci"},{"key":"9550_CR2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780360812","volume":"36","author":"D Aderka","year":"2010","unstructured":"Aderka, D., Wysenbeek, A., Engelmann, H., Cope, A.P., Brennan, F., Molad, Y., Hornik, V., Levo, Y., Maini, R.N., Feldmann, M., et al. (2010). Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthrit Rheumat 36, 1111\u20131120.","journal-title":"Arthrit Rheumat"},{"key":"9550_CR3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/imt.11.68","volume":"3","author":"R Bhadra","year":"2011","unstructured":"Bhadra, R., Gigley, J.P., and Khan, I.A. (2011a). The CD8 T-cell road to immunotherapy of toxoplasmosis. Immunotherapy 3, 789\u2013801.","journal-title":"Immunotherapy"},{"key":"9550_CR4","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1073\/pnas.1015298108","volume":"108","author":"R Bhadra","year":"2011","unstructured":"Bhadra, R., Gigley, J.P., Weiss, L.M., and Khan, I.A. (2011b). Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci USA 108, 9196\u20139201.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9550_CR5","doi-asserted-by":"crossref","first-page":"e20932","DOI":"10.1371\/journal.pone.0020932","volume":"6","author":"C Cheng","year":"2011","unstructured":"Cheng, C., Ho, W.E., Goh, F.Y., Guan, S.P., Kong, L.R., Lai, W.Q., Leung, B.P., and Wong, W.S.F. (2011). Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase\/Akt pathway. PLoS ONE 6, e20932.","journal-title":"PLoS ONE"},{"key":"9550_CR6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s004360000358","volume":"87","author":"B Chimanuka","year":"2001","unstructured":"Chimanuka, B., Francois, G., Timperman, G., Heyden, Y.V., Holenz, J., Plaizier-Vercammen, J., and Bringmann, G. (2001). A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo. Parasitol Res 87, 795\u2013803.","journal-title":"Parasitol Res"},{"key":"9550_CR7","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1128\/IAI.73.12.8060-8068.2005","volume":"73","author":"KN Couper","year":"2005","unstructured":"Couper, K.N., Roberts, C.W., Brombacher, F., Alexander, J., and Johnson, L.L. (2005). Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion. Infect Immun 73, 8060\u20138068.","journal-title":"Infect Immun"},{"key":"9550_CR8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cei.13073","volume":"191","author":"DJ Cruz-Gonz\u00e1lez","year":"2018","unstructured":"Cruz-Gonz\u00e1lez, D.J., G\u00f3mez-Martin, D., Layseca-Espinosa, E., Baranda, L., Abud-Mendoza, C., Alcocer-Varela, J., Gonz\u00e1lez-Amaro, R., and Monsiv\u00e1is-Urenda, A.E. (2018). Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus. Clin Exp Immunol 191, 288\u2013300.","journal-title":"Clin Exp Immunol"},{"key":"9550_CR9","first-page":"676","volume":"23","author":"YJ Dong","year":"2003","unstructured":"Dong, Y.J., Li, W.D., and Tu, Y.Y. (2003) Effect of dihydro-qinghaosu on auto-antibody production, TNF alpha secretion and pathologic change of lupus nephritis in BXSB mice (in Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 23, 676\u2013679.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"9550_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopha.2013.01.013","volume":"67","author":"XX Du","year":"2013","unstructured":"Du, X.X., Li, Y.J., Wu, C.L., Zhou, J.H., Han, Y., Sui, H., Wei, X.L., Liu, L., Huang, P., Yuan, H.H., et al. (2013). Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin. Biomed Pharmacother 67, 417\u2013424.","journal-title":"Biomed Pharmacother"},{"key":"9550_CR11","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/AAC.00502-09","volume":"53","author":"IR Dunay","year":"2009","unstructured":"Dunay, I.R., Chan, W.C., Haynes, R.K., and Sibley, L.D. (2009). Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrobial Agents Chemother 53, 4450\u20134456.","journal-title":"Antimicrobial Agents Chemother"},{"key":"9550_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth, T. (2017). From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Seminars Cancer Biol 46, 65\u201383.","journal-title":"Seminars Cancer Biol"},{"key":"9550_CR13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1475-2875-11-268","volume":"11","author":"Y Feng","year":"2012","unstructured":"Feng, Y., Zhu, X., Wang, Q., Jiang, Y., Shang, H., Cui, L., and Cao, Y. (2012). Allicin enhances host pro-inflammatory immune responses and protects against acute murine malaria infection. Malar J 11, 268.","journal-title":"Malar J"},{"key":"9550_CR14","first-page":"73","volume":"38","author":"C Gordon","year":"2009","unstructured":"Gordon, C., Li, C.K., and Isenberg, D.A. (2009). Systemic lupus erythematosus. N Engl J Med 38, 73\u201380.","journal-title":"N Engl J Med"},{"key":"9550_CR15","first-page":"34","volume":"9","author":"Y Guo","year":"1997","unstructured":"Guo, Y., Xu, P., Xuan, Y., Wu, L., and Li, S. (1997) Effect of artesunate on vltrastructure of schistosomula Schistosoma japonicum (in Chinese). Chin J Schistosom Contr 9, 34\u201336.","journal-title":"Chin J Schistosom Contr"},{"key":"9550_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00296-009-1218-7","volume":"31","author":"Y He","year":"2011","unstructured":"He, Y., Fan, J., Lin, H., Yang, X., Ye, Y., Liang, L., Zhan, Z., Dong, X., Sun, L., and Xu, H. (2011). The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1\u03b1 in human rheumatoid arthritis fibroblast-like synoviocyte. Rheumatol Int 31, 53\u201360.","journal-title":"Rheumatol Int"},{"key":"9550_CR17","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.30392","volume":"63","author":"LF Hou","year":"2011","unstructured":"Hou, L.F., He, S.J., Li, X., Yang, Y., He, P.L., Zhou, Y., Zhu, F.H., Yang, Y. F., Li, Y., Tang, W., et al. (2011). Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses. Arthrit Rheumat 63, 2445\u20132455.","journal-title":"Arthrit Rheumat"},{"key":"9550_CR18","doi-asserted-by":"crossref","first-page":"e104762","DOI":"10.1371\/journal.pone.0104762","volume":"9","author":"L Hou","year":"2014","unstructured":"Hou, L., Block, K.E., and Huang, H. (2014). Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis. PLoS ONE 9, e104762.","journal-title":"PLoS ONE"},{"key":"9550_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.intimp.2014.07.001","volume":"22","author":"X Huang","year":"2014","unstructured":"Huang, X., Xie, Z., Liu, F., Han, C., Zhang, D., Wang, D., Bao, X., Sun, J., Wen, C., and Fan, Y. (2014). Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL\/lpr mice. Int Immunopharmacol 22, 266\u2013272.","journal-title":"Int Immunopharmacol"},{"key":"9550_CR20","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.1104063108","volume":"108","author":"N Klonis","year":"2011","unstructured":"Klonis, N., Crespo-Ortiz, M.P., Bottova, I., Abu-Bakar, N., Kenny, S., Rosenthal, P.J., and Tilley, L. (2011). Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc Natl Acad Sci USA 108, 11405\u201311410.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9550_CR21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4049\/jimmunol.148.2.568","volume":"148","author":"JA Langermans","year":"1992","unstructured":"Langermans, J.A., Van der Hulst, M.E., Nibbering, P.H., Hiemstra, P.S., Fransen, L., and Van Furth, R. (1992). IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol 148, 568\u2013574.","journal-title":"J Immunol"},{"key":"9550_CR22","first-page":"85","volume":"15","author":"JE Lewis","year":"2013","unstructured":"Lewis, J.E., Fu, S.M., and Gaskin, F. (2013). Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus. Discov Med 15, 85\u201392.","journal-title":"Discov Med"},{"key":"9550_CR23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0035-9203(94)90460-X","volume":"88","author":"GQ Li","year":"1994","unstructured":"Li, G.Q., Guo, X.B., Fu, L.C., Jian, H.X., and Wang, X.H. (1994). Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hygiene 88, 5\u20136.","journal-title":"Trans R Soc Trop Med Hygiene"},{"key":"9550_CR24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.intimp.2011.11.004","volume":"12","author":"T Li","year":"2012","unstructured":"Li, T., Chen, H., Wei, N., Mei, X., Zhang, S., Liu, D., Gao, Y., Bai, S., Liu, X., and Zhou, Y. (2012). Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity. Int Immunopharmacol 12, 144\u2013150.","journal-title":"Int Immunopharmacol"},{"key":"9550_CR25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.intimp.2013.03.011","volume":"16","author":"T Li","year":"2013","unstructured":"Li, T., Chen, H., Yang, Z., Liu, X.G., Zhang, L.M., and Wang, H. (2013a). Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo. Int Immunopharmacol 16, 306\u2013312.","journal-title":"Int Immunopharmacol"},{"key":"9550_CR26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","volume":"6","author":"W Li","year":"2006","unstructured":"Li, W., Dong, Y., Tu, Y., and Lin, Z. (2006). Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int Immunopharmacol 6, 1243\u20131250.","journal-title":"Int Immunopharmacol"},{"key":"9550_CR27","doi-asserted-by":"crossref","first-page":"e74108","DOI":"10.1371\/journal.pone.0074108","volume":"8","author":"X Li","year":"2013","unstructured":"Li, X., Li, T.T., Zhang, X.H., Hou, L.F., Yang, X.Q., Zhu, F.H., Tang, W., and Zuo, J.P. (2013b). Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell. PLoS ONE 8, e74108.","journal-title":"PLoS ONE"},{"key":"9550_CR28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/aps.2012.104","volume":"33","author":"Y Li","year":"2012","unstructured":"Li, Y. (2012). Qinghaosu (artemisinin): Chemistry and pharmacology. Acta Pharmacol Sin 33, 1141\u20131146.","journal-title":"Acta Pharmacol Sin"},{"key":"9550_CR29","first-page":"811","volume":"92","author":"N Listed","year":"1979","unstructured":"Listed, N. (1979). Antimalaria studies on Qinghaosu. Chin Med J (Engl) 92, 811\u2013816.","journal-title":"Chin Med J (Engl)"},{"key":"9550_CR30","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.4049\/jimmunol.0804214","volume":"182","author":"EV Lourenco","year":"2009","unstructured":"Lourenco, E.V., Procaccini, C., Ferrera, F., Iikuni, N., Singh, R.P., Filaci, G., Matarese, G., Shi, F.D., Brahn, E., Hahn, B.H., et al. (2009). Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB \u00d7 NZW)F1 lupus mice. J Immunol 182, 7415\u20137421.","journal-title":"J Immunol"},{"key":"9550_CR31","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1172\/JCI116153","volume":"90","author":"DG Mack","year":"1992","unstructured":"Mack, D.G., and Mcleod, R. (1992). Human Toxoplasma gondii-specific secretory immunoglobulin A reduces T. gondii infection of enterocytes in vitro. J Clin Invest 90, 2585\u20132592.","journal-title":"J Clin Invest"},{"key":"9550_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10753-015-0262-6","volume":"39","author":"H Mahmoudvand","year":"2016","unstructured":"Mahmoudvand, H., Ziaali, N., Ghazvini, H., Shojaee, S., Keshavarz, H., Esmaeilpour, K., and Sheibani, V. (2016). Toxoplasma gondii infection promotes neuroinflammation through cytokine networks and induced hyperalgesia in BALB\/c mice. Inflammation 39, 405\u2013412.","journal-title":"Inflammation"},{"issue":"1","key":"9550_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/374696","volume":"2009","author":"J Matowicka-Karna","year":"2009","unstructured":"Matowicka-Karna, J., Dymicka-Piekarska, V., and Kemona, H. (2009). Does Toxoplasma gondii Infection Affect the Levels of IgE and Cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin Dev Immunol 2009(1), 1\u20134.","journal-title":"Clin Dev Immunol"},{"key":"9550_CR34","first-page":"492","volume":"5","author":"CS Meira","year":"2014","unstructured":"Meira, C.S., Pereira-Chioccola, V.L., Vidal, J.E., de Mattos, C.C.B., Motoie, G., Costa-Silva, T.A., Gava, R., Frederico, F.B., and de Mattos, L.C. (2014). Cerebral and ocular toxoplasmosis related with IFN-\u03b3, TNF-\u03b1, and IL-10 levels. Front Microbiol 5, 492.","journal-title":"Front Microbiol"},{"key":"9550_CR35","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","volume":"32","author":"SR Meshnick","year":"2002","unstructured":"Meshnick, S.R. (2002). Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 32, 1655\u20131660.","journal-title":"Int J Parasitol"},{"key":"9550_CR36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-065X.2010.00992.x","volume":"240","author":"M Munoz","year":"2015","unstructured":"Munoz, M., Liesenfeld, O., and Heimesaat, M.M. (2015). Immunology of Toxoplasma gondii.Immunol Rev 240, 269\u2013285.","journal-title":"Immunol Rev"},{"key":"9550_CR37","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/EC.00262-07","volume":"6","author":"K Nagamune","year":"2007","unstructured":"Nagamune, K., Beatty, W.L., and Sibley, L.D. (2007). Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii. Eukaryot Cell 6, 2147\u20132156.","journal-title":"Eukaryot Cell"},{"key":"9550_CR38","unstructured":"Qinghaosu Research Group, Institute of Biophysics Academia Sinica. (1980). Crystal structure and absolute configuration of Qinghaosu. Sci China Ser A, 380\u2013396."},{"key":"9550_CR39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","volume":"359","author":"N Shakoor","year":"2002","unstructured":"Shakoor, N., Michalska, M., Harris, C.A., and Block, J.A. (2002). Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 359, 579\u2013580.","journal-title":"Lancet"},{"key":"9550_CR40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/330664a0","volume":"330","author":"L Schofield","year":"1987","unstructured":"Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R., and Nussenzweig, V. (1987). \u03b3 Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664\u2013666.","journal-title":"Nature"},{"key":"9550_CR41","doi-asserted-by":"crossref","first-page":"45981","DOI":"10.18632\/oncotarget.17520","volume":"8","author":"X Shi","year":"2017","unstructured":"Shi, X., Wang, L., Li, X., Bai, J., Li, J., Li, S., Wang, Z., and Zhou, M. (2017). Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA doublestrand break-mediated oxidative stress. Oncotarget 8, 45981\u201345993.","journal-title":"Oncotarget"},{"key":"9550_CR42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","volume":"1","author":"MJ Shlomchik","year":"2001","unstructured":"Shlomchik, M.J., Craft, J.E., and Mamula, M.J. (2001). From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1, 147\u2013153.","journal-title":"Nat Rev Immunol"},{"key":"9550_CR43","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.4049\/jimmunol.147.7.2340","volume":"147","author":"LD Sibley","year":"1991","unstructured":"Sibley, L.D., Adams, L.B., Fukutomi, Y., and Krahenbuhl, J.L. (1991). Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages. J Immunol 147, 2340\u20132345.","journal-title":"J Immunol"},{"key":"9550_CR44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0020-7519(96)89380-5","volume":"26","author":"TS Skinner","year":"1996","unstructured":"Skinner, T.S., Manning, L.S., Johnston, W.A., and Davis, T.M.E. (1996). In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int J Parasitol 26, 519\u2013525.","journal-title":"Int J Parasitol"},{"key":"9550_CR45","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/rheumatology\/35.11.1067","volume":"35","author":"A Studnicka-Benke","year":"1996","unstructured":"Studnicka-Benke, A., Steiner, G., Petera, P., and Smolen, J.S. (1996). Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Rheumatology 35, 1067\u20131074.","journal-title":"Rheumatology"},{"key":"9550_CR46","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni1376","volume":"7","author":"JS Stumhofer","year":"2006","unstructured":"Stumhofer, J.S., Laurence, A., Wilson, E.H., Huang, E., Tato, C.M., Johnson, L.M., Villarino, A.V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006). Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7, 937\u2013945.","journal-title":"Nat Immunol"},{"key":"9550_CR47","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1007\/s13277-013-0963-0","volume":"34","author":"H Sun","year":"2013","unstructured":"Sun, H., Meng, X., Han, J., Zhang, Z., Wang, B., Bai, X., and Zhang, X. (2013). Anti-cancer activity of DHA on gastric cancer\u2014an in vitro and in vivo study. Tumor Biol 34, 3791\u20133800.","journal-title":"Tumor Biol"},{"key":"9550_CR48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1084\/jem.20071133","volume":"205","author":"M Tajima","year":"2008","unstructured":"Tajima, M., Wakita, D., Noguchi, D., Chamoto, K., Yue, Z., Fugo, K., Ishigame, H., Iwakura, Y., Kitamura, H., and Nishimura, T. (2008). IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med 205, 1019\u20131027.","journal-title":"J Exp Med"},{"key":"9550_CR49","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G.C. (2011). Systemic lupus erythematosus. N Engl J Med 365, 2110\u20132121.","journal-title":"N Engl J Med"},{"key":"9550_CR50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0001-706X(01)00138-3","volume":"80","author":"J Utzinger","year":"2001","unstructured":"Utzinger, J., Chollet, J., You, J., Mei, J., Tanner, M., and Xiao, S. (2001). Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop 80, 9\u201318.","journal-title":"Acta Trop"},{"key":"9550_CR51","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4049\/jimmunol.1100241","volume":"187","author":"A Villegas-Mendez","year":"2011","unstructured":"Villegas-Mendez, A., de Souza, J.B., Murungi, L., Hafalla, J.C.R., Shaw, T. N., Greig, R., Riley, E.M., and Couper, K.N. (2011). Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection. J Immunol 187, 2885\u20132897.","journal-title":"J Immunol"},{"key":"9550_CR52","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0903416","volume":"184","author":"MS Wilson","year":"2010","unstructured":"Wilson, M.S., Feng, C.G., Barber, D.L., Yarovinsky, F., Cheever, A.W., Sher, A., Grigg, M., Collins, M., Fouser, L., and Wynn, T.A. (2010). Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 184, 4378\u20134390.","journal-title":"J Immunol"},{"key":"9550_CR53","first-page":"267","volume":"5","author":"L Wu","year":"1996","unstructured":"Wu, L., Xu, Y., Guo, Y., Xu, P., and Li, S. (1996). Studies on the effect of artesunate to the energy-metabolic enzymes (in Chinese). Chin J Schistosom Contr 5, 267\u2013269.","journal-title":"Chin J Schistosom Contr"},{"key":"9550_CR54","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/eji.200425267","volume":"34","author":"X Wen","year":"2004","unstructured":"Wen, X., Zhang, D., Kikuchi, Y., Jiang, Y., Nakamura, K., Xiu, Y., Tsurui, H., Takahashi, K., Abe, M., Ohtsuji, M., et al. (2004). Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. Eur J Immunol 34, 2740\u20132749.","journal-title":"Eur J Immunol"},{"key":"9550_CR55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0169-4758(99)01601-4","volume":"16","author":"SH Xiao","year":"2000","unstructured":"Xiao, S.H., Booth, M., and Tanner, M. (2000). The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol Today 16, 122\u2013126.","journal-title":"Parasitol Today"},{"key":"9550_CR56","doi-asserted-by":"crossref","first-page":"89486","DOI":"10.18632\/oncotarget.19002","volume":"8","author":"C Xing","year":"2017","unstructured":"Xing, C., Zhu, G., Xiao, H., Fang, Y., Liu, X., Han, G., Chen, G., Hou, C., Shen, B., Li, Y., et al. (2017). B cells regulate thymic CD8+T cell differentiation in lupus-prone mice. Oncotarget 8, 89486\u201389499.","journal-title":"Oncotarget"},{"key":"9550_CR57","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.3892\/mmr.2017.7832","volume":"16","author":"CH Xu","year":"2017","unstructured":"Xu, C.H., Liu, Y., Xiao, L.M., Guo, C.G., Zheng, S.Y., Zeng, E.M., and Li, D.H. (2017). Dihydroartemisinin treatment exhibits antitumor effects in glioma cells through induction of apoptosis. Mol Med Rep 16, 9528\u20139532.","journal-title":"Mol Med Rep"},{"key":"9550_CR58","first-page":"19","volume":"1","author":"LM Xu","year":"2002","unstructured":"Xu, L.M., Chen, X.R., and Tu, Y.Y. (2002). Effect of hydroartemisinin on lupus BXSB mice (in Chinese). Chin J Dermatovenerol Integr Trad West Med 1, 19\u201320.","journal-title":"Chin J Dermatovenerol Integr Trad West Med"},{"key":"9550_CR59","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","volume":"46","author":"H Xu","year":"2007","unstructured":"Xu, H., He, Y., Yang, X., Liang, L., Zhan, Z., Ye, Y., Yang, X., Lian, F., and Sun, L. (2007). Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology 46, 920\u2013926.","journal-title":"Rheumatology"},{"key":"9550_CR60","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/10799893.2016.1203942","volume":"37","author":"S Zhang","year":"2017","unstructured":"Zhang, S., Shi, L., Ma, H., Li, H., Li, Y., Lu, Y., Wang, Q., and Li, W. (2017). Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1\/2 and p38 MAPK signaling pathways. J Recept Signal Transduct 37, 174\u2013180.","journal-title":"J Recept Signal Transduct"},{"key":"9550_CR61","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.18632\/oncotarget.3336","volume":"6","author":"X Zhao","year":"2015","unstructured":"Zhao, X., Zhong, H., Wang, R., Liu, D., Waxman, S., Zhao, L., and Jing, Y. (2015) Dihydroartemisinin and its derivative induce apoptosis in acute myeloid leukemia through Noxa-mediated pathway requiring iron and endoperoxide moiety. Oncotarget 6, 5582\u20135596.","journal-title":"Oncotarget"},{"key":"9550_CR62","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.4049\/jimmunol.1200919","volume":"189","author":"YG Zhao","year":"2012","unstructured":"Zhao, Y.G., Wang, Y., Guo, Z., Gu, A., Dan, H.C., Baldwin, A.S., Hao, W., and Wan, Y.Y. (2012). Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway. J Immunol 189, 4417\u20134425.","journal-title":"J Immunol"},{"key":"9550_CR63","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1745-7254.2005.00232.x","volume":"26","author":"W Zhou","year":"2010","unstructured":"Zhou, W., Wu, J., Wu, Q., Wang, J., Zhou, Y., Zhou, R., He, P., Li, X., Yang, Y., Zhang, Y., et al. (2010). A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo. Acta Pharmacol Sin 26, 1352\u20131358.","journal-title":"Acta Pharmacol Sin"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-019-9550-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-019-9550-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-019-9550-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T03:07:53Z","timestamp":1695006473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-019-9550-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["9550"],"URL":"https:\/\/doi.org\/10.1007\/s11427-019-9550-4","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<b>Compliance and ethics<\/b> The author(s) declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}